Clene CLNN 深 沪
已收盘 08-21 16:00:00 美东时间
4.32
-0.050
-1.14%
华盛通- 最 高4.41
- 今 开4.40
- 成交量 2.89万股
- 最 低 4.1326
- 昨 收 4.37
- 总市值 5550.56万
- 52周最高 13.50
- 市盈率 静 --
- 换手率 0.22%
- 52周最低 3.88
- 委 比 -75.00%
- 总股本 1284.85万
- 历史最高 356.40
- 量 比 0.55
- 振 幅 6.35%
- 历史最低 2.2801
- 每 手 1
- 风险率 1.57%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Clene Announces Biomarker Analyses To Be Included in NDA Submission Supporting ALS Accelerated Approval
Clene Inc. announced new analyses showing that CNM-Au8-treated ALS patients with stabilized or decreased neurofilament light chain (NfL) levels had significantly longer survival and better functional outcomes compared to controls. These findings address FDA questions and aim to support accelerated approval. NfL, a biomarker of nerve cell injury, was found to correlate with clinical benefits, including slower disease progression and improved daily...
08-10 12:00
加州富豪开始数百公里的迁徙，原因竟是这个
①美国加州拟征财富税，推动不少亿万富豪涌入内华达州太浩湖旁的因克莱恩村和水晶湾； ②太浩湖北岸因历史划界脱离加州税管，富豪们于此地居住可实现税务与生活的双重套利； ③该征税提案引发多方反对，但超级富豪们仍加速转移资产与居所。
06-10 17:31
Clene Q1 GAAP每股亏损0.69美元，营收仅1万美元
临床阶段生物制药公司Clene周四公布2026年第一季度财报。公司GAAP每股亏损0.69美元，营收仅1万美元，远低于市场预期。不过，公司在ALS药物CN...
05-14 22:45
Clene Q1 EPS $(0.69) Misses $(0.66) Estimate, Sales $15.000K Miss $35.064K Estimate
Clene (NASDAQ:CLNN) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.66) by 4.55 percent. This is a 666.67 percent decrease over losses of $(0.09) per share from the same
05-14 20:39
Clene Reports First Quarter 2026 Financial Results and Recent Operating Highlights
Clene Inc. announced its Q1 2026 financial results and updates on its CNM-Au8 programs for treating neurodegenerative diseases like ALS and MS. The company successfully completed an FDA Type C meeting and plans to submit an NDA under the accelerated approval pathway in Q3 2026. Clene also completed multiple financings totaling over $35 million and amended its debt facility to extend maturity. Despite a net loss of $8.1 million, the company expect...
05-14 12:00
Transcript: Enlight Renewable Energy Q1 2026 Earnings Conference Call
Enlight Renewable Energy (NASDAQ:ENLT) released first-quarter financial results...
05-05 21:09
Clene prices $7M registered direct offering
Clene (CLNN) and its wholly owned subsidiary, Clene Nanomedicine on Tuesday announced the pricing of an underwritten registered direct offering of 1M shares of common stock at a purchase price of $7.0...
05-05 21:03
美股大行评级 | 潜在涨幅85%！SoFi获机构升目标价至49美元；华尔街大行看涨AMD至400美元
今日重点评级关注：Canaccord Genuity：维持Sagimet Biosciences"买入"评级，目标价从28美元升至49美元；HC Wainwright & Co.：维持Fate Therapeutics"买入"评级，目标价从5美元升至7美元
05-05 11:40
Clene Advances CNM-Au8 Toward Accelerated ALS Approval
An announcement from Clene ( ($CLNN) ) is now available. On May 4, 2026, Clene ...
05-04 20:33
